Found 22 matching trials
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH) PHASE3 This study was an international, multicenter, randomized (2:1 active:placeb...
Show More Location
University of Alabama-Birmingham
Learn More & Join Trial
Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine PHASE2 This study will evaluate the effect of treprostinil diethanolamine (UT-15C)...
Show More Location
University of Alabama - Arthritis Clinical Intervention Program
Learn More & Join Trial
An Open-Label Extension Trial of UT-15C Sustained-release (SR) in Subjects With Pulmonary Arterial Hypertension PHASE3 This study provided/continued to provide oral treprostinil (UT-15C SR; trep...
Show More Location
The Kirklin Clinic
Learn More & Join Trial
Pharmacokinetic Linearity and Comparative Bioavailability of Treprostinil Diethanolamine PHASE1 This study will compare the bioavailability and pharmacokinetics of the 0.5...
Show More Learn More & Join Trial
Open-label Extension of Oral Treprostinil in Subjects With PH Associated With HFpEF PHASE3 This was an open-label study to evaluate the safety of continued therapy wi...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso® PHASE2 The purpose of this multi-center, open-label, safety and tolerability study...
Show More Location
The University of Alabama at Birmingham
Learn More & Join Trial
Study to Compare Triple Therapy (Oral Treprostinil, Ambrisentan, and Tadalafil) With Dual Therapy (Ambrisentan, Tadalafil, and Placebo) in Subjects With Pulmonary Arterial Hypertension PHASE3 This is a multicenter, randomized (2:1 oral treprostinil: placebo), double-...
Show More Location
Multiple Locations
Learn More & Join Trial
A Pharmacokinetic Substudy of the TDE-PH-304 Protocol PHASE3 A sub-study to the TDE-PH-304 protocol to assess the pharmacokinetics of pa...
Show More Location
University of Rochester Medical Center
Learn More & Join Trial
A Dose Response Study of UT-15C SR in Patients With Exercise-Induced Pulmonary Hypertension PHASE2 This is a prospective, randomized, parallel group study to assess the hemod...
Show More Location
St. Joseph's Hospital and Medical Center
Learn More & Join Trial
Pharmacokinetics of Oral Treprostinil in Patients With Systemic Sclerosis PHASE1 This study will assess the pharmacokinetic and safety profile of treprostin...
Show More Location
Johns Hopkins Scleroderma Center
Learn More & Join Trial